Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter.
The Clinical Benefits of HDx Therapy for Chronic HD Patients
The Nephrology Dialysis Transplantation (NDT) Journal has published results of two clinical studies comparing with Theranova dialyzer with the latest generation of high-flux dialyzers.Read More
A Focus on Clinical Research
Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study. - le Poole CY, et al.
A 3-Year, Prospective, Randomized, Controlled Study on Amino Acid Dialysate in Patients on CAPD - Li FK, et al.
Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution - Otte K, et al.
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS) - Marshall J, et al.
Icodextrin Improves the Fluid Status of Peritoneal Dialysis Patients: Results of a Double-Blind Randomized Controlled Trial - Davies SJ, et al.
Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis - Plum J, et al.
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels - Jones S, et al.